Form D · Pharmaceuticals
TRIGEMINA INC
Mountain View, CA · CIK 0001385405
Offering snapshot reported Nov 18, 2010 · SEC filing
- Reported sold
- $400K Offering amount: $2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 5, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2010 | Initial | $400,000 | No comparison | 6 | SEC filing |
| Dec 23, 2009 | Initial | $304,967 | No comparison | 3 | SEC filing |
| Dec 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-150703
Source: Form D, filed Nov 18, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Benham | Director |
| Urs Holzle | Director |
| Daniel Jacobs | Director, Executive |
| Mark Mc Camish | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
809 B Cuesta Drive Ste 109
Mountain View, CA, 94040
Mountain View, CA, 94040